The University of Central Lancashire is co-leading the first and largest human trial of its kind. A study found that patients ...

Following the study, the FDA approved the use of Tremfya to treat moderately to severely active ulcerative colitis. In ...

The appendix is thought to play a role in all of this by producing inflammatory proteins that trigger the body to produce ...

In a new First Opinion essay, Borio and Krause, both once top FDA officials, say the commissioner made a “rookie misstep” in ...

With the introduction of a subcutaneous formulation, ENTYVIO has expanded patient convenience and global accessibility. Continued growth is supported by rising IBD prevalence and ongoing geographic ...

OSE Immunotherapeutics to Present Groundbreaking Extension Period Data on Lusvertikimab at DDW 2025New Clinical Data from ...

Ulcerative colitis causes inflammation and ulcers in ... but almost all were mild or moderate, according to the researchers. An editorial, opens new tab published with the report notes that ...

Results from a subgroup of the ICONIC-LEAD study show 75% of adolescents with plaque psoriasis achieved completely clear skin ...

A significant proportion of children newly diagnosed with IBD present with anaemia, and many of them remain anaemic even ...